Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 3,107Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 71AXSOME MALTA

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

SOLRIAMFETOL HYDROCHLORIDE

US Patent Number : 8440715

Drug Substance Claim :

Drug Product Claim :

Application Number : 211230

Patent Use Code : U-2548

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-06-11

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

SOLRIAMFETOL HYDROCHLORIDE

US Patent Number : 9604917

Drug Substance Claim :

Drug Product Claim :

Application Number : 211230

Patent Use Code : U-2548

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-06-07

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

SOLRIAMFETOL HYDROCHLORIDE

US Patent Number : 9604917

Drug Substance Claim :

Drug Product Claim :

Application Number : 211230

Patent Use Code : U-2548

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-06-07

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

SOLRIAMFETOL HYDROCHLORIDE

US Patent Number : 8440715

Drug Substance Claim :

Drug Product Claim :

Application Number : 211230

Patent Use Code : U-2548

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-06-11

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

SOLRIAMFETOL HYDROCHLORIDE

US Patent Number : 10351517

Drug Substance Claim :

Drug Product Claim :

Application Number : 211230

Patent Use Code : U-2548

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-06-07

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

SOLRIAMFETOL HYDROCHLORIDE

US Patent Number : 10351517

Drug Substance Claim :

Drug Product Claim :

Application Number : 211230

Patent Use Code : U-2548

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-06-07

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

SOLRIAMFETOL HYDROCHLORIDE

US Patent Number : 10512609

Drug Substance Claim :

Drug Product Claim :

Application Number : 211230

Patent Use Code : U-2548

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-09-05

blank

08

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

SOLRIAMFETOL HYDROCHLORIDE

US Patent Number : 10512609

Drug Substance Claim :

Drug Product Claim :

Application Number : 211230

Patent Use Code : U-2548

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-09-05

blank

09

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

SOLRIAMFETOL HYDROCHLORIDE

US Patent Number : 11560354

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 211230

Patent Use Code : U-3520

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-03-06

blank

10

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

SOLRIAMFETOL HYDROCHLORIDE

US Patent Number : 11560354

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 211230

Patent Use Code : U-3520

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-03-06

blank